CN102727711A - 一种治疗慢性疲劳综合症的中药 - Google Patents
一种治疗慢性疲劳综合症的中药 Download PDFInfo
- Publication number
- CN102727711A CN102727711A CN2012101923147A CN201210192314A CN102727711A CN 102727711 A CN102727711 A CN 102727711A CN 2012101923147 A CN2012101923147 A CN 2012101923147A CN 201210192314 A CN201210192314 A CN 201210192314A CN 102727711 A CN102727711 A CN 102727711A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- chronic fatigue
- fatigue syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 title claims abstract description 19
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 title claims abstract description 19
- 241000005787 Cistanche Species 0.000 claims abstract description 9
- 229940079593 drug Drugs 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 12
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 30
- 210000000988 bone and bone Anatomy 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 241000234276 Curculigo Species 0.000 abstract 1
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000244355 Ligusticum Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 241000736199 Paeonia Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 38
- 210000004185 liver Anatomy 0.000 description 37
- 210000003734 kidney Anatomy 0.000 description 34
- 239000008280 blood Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 27
- 230000007812 deficiency Effects 0.000 description 26
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 210000003414 extremity Anatomy 0.000 description 15
- 206010012735 Diarrhoea Diseases 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 14
- 208000019255 Menstrual disease Diseases 0.000 description 11
- 208000002173 dizziness Diseases 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 210000003205 muscle Anatomy 0.000 description 11
- 230000001105 regulatory effect Effects 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 10
- 206010022437 insomnia Diseases 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- 210000003127 knee Anatomy 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 206010063659 Aversion Diseases 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 8
- 206010037660 Pyrexia Diseases 0.000 description 8
- 208000009205 Tinnitus Diseases 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 230000002269 spontaneous effect Effects 0.000 description 8
- 231100000886 tinnitus Toxicity 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 7
- 208000008454 Hyperhidrosis Diseases 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 201000001881 impotence Diseases 0.000 description 7
- 230000007958 sleep Effects 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 206010016256 fatigue Diseases 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 206010061428 decreased appetite Diseases 0.000 description 5
- 206010036596 premature ejaculation Diseases 0.000 description 5
- 230000035900 sweating Effects 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 208000021267 infertility disease Diseases 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000012886 Vertigo Diseases 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 230000035568 catharsis Effects 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- -1 coumarin, flavone Chemical class 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000008451 emotion Effects 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000004356 Hysteria Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- ZZAJQOPSWWVMBI-UHFFFAOYSA-N calycosin Chemical compound C1=C(O)C(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZZAJQOPSWWVMBI-UHFFFAOYSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000012839 conversion disease Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 210000001097 facial muscle Anatomy 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000008563 guizhi decoction Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229930188824 alisol Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000003161 proteinsynthetic effect Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000003191 uterotonic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种治疗慢性疲劳综合症的中药,其是由下述重量份的原料药制成:当归10-15,桂枝10-12,白芍10-15,熟地10-15,枸杞10-12,黄芪15-30,菟丝子10-20,山药30-60,淫羊藿10-15,肉苁蓉15-30,杜仲10-15,茯苓10-20,西洋参10-12,陈皮10-12,牡蛎15-30,柴胡10-12,仙茅10-15,泽泻10-12,丹皮10-15,龙骨15-30,大枣10-15。本发明工艺简单,治疗方便,见效快,无毒副作用,愈后不复发,费用成本低。
Description
技术领域
本发明涉及中药领域,确切地说是一种治疗慢性疲劳综合症的中药。
背景技术
现代中医学认为,慢性疲劳综合症为一个病名,归于亚健康范畴,是现代高效快节奏生活方式下出现的一组以长期极度疲劳(包括体力疲劳和脑力疲劳)为主要突出表现的全身性症候群,是必须重视的新病种。一般表现为:记忆力减退,烦躁易怒,肢体疲乏,精力不足,头晕头痛、失眠健忘、肌肉关节疼痛,食欲不振、腹痛腹泻,脱发断发,皱纹早现,面肌松弛,自汗、盗汗,畏寒肢冷,男子遗精,阳痿早泄,女子月经失调,不孕等,明显呈现出未老先衰之征象。其病因病机,临床涉及五脏六腑,主要以脾、肝、肾为主。脾为后天之本,气血生化之源,主肌肉、四肢,脾失健运,则气血生化乏源,清阳不升、浊阴不降,四肢肌肉失养故见四肢酸痛无力、头晕头痛、食欲不振、腹胀腹泻等。吴崑《医方考》曰“夫面色萎白,则望之而知其气虚矣;言语轻微,则闻之而知其气虚矣;四肢无力,则问而知其气虚矣;脉来虚弱,则切而知其气虚矣”。肾为先天之本,主藏精,主生殖,主骨生髓通于脑,其华在发,《灵枢 海论》说“脑为髓海”及“髓海不足,则脑转耳鸣,胫酸眩冒”,肾精气不足则精力不足,脱发断发,肢体酸懒、耳鸣、精神昏愦、记忆力减退、或有腰膝酸软,足跟酸痛,皱纹早现,畏寒肢冷,男子遗精,阳痿早泄。肝藏血,主疏泄,调畅情志,正如《素问·六节藏象论》篇云:“肝者罢极之本”,明确指出肝脏功能失调是产生疲劳的重要原因。肝藏魂,魂与神密切相关,可影响心理活动,神经活动过度会影响肝,从而降低肌肉活动能力。肝主筋,筋连属关节,“诸筋者属于节。”肝伤阴亏,则疏泄失司,可见月经失调,胁肋疼痛,步履不坚等。慢性疲劳综合症西医学在治疗以上病症时只是对症治疗,只解决表面现象,疗效不理想或没有疗效。故可以通过中医辨证组方调治,以达到预防、治疗、控制的目的。
发明内容
本发明的目的是为避免上述现有技术所存在的不足之处,提供一种治疗慢性疲劳综合症的中药,以期对慢性疲劳综合症治疗获得效果好,见效快,治愈率高的治疗目标。
本发明采用如下技术方案:
一种治疗慢性疲劳综合症的中药,其特征在于,其是由下列重量份的原料药制成:当归10-15,桂枝10-12,白芍10-15,熟地10-15, 枸杞10-12,黄芪 15-30, 菟丝子10-20,山药30-60,淫羊藿10-15,肉苁蓉 15-30,杜仲10-15,茯苓10-20,西洋参10-12,陈皮10-12,牡蛎15-30,柴胡10-12,仙茅10-15,泽泻10-12,丹皮10-15,龙骨15-30,大枣10-15。
所述的治疗慢性疲劳综合症的中药,其特征在于:其是由下列重量份的原料药制成:当归10,桂枝10,白芍12,熟地12, 枸杞10,黄芪 30, 菟丝子20,山药30,淫羊藿15,肉苁蓉 20, 杜仲12,茯苓15,西洋参10,陈皮10,牡蛎30,柴胡10,仙茅15,泽泻10,丹皮10,龙骨30,大枣10。
所述的治疗慢性疲劳综合症的中药,其特征在于:制备方法包括以下步骤:
(1)、按重量份取各原料混匀,再用粉碎机粉碎,后过80目筛,得药粉;
(2)、药粉用紫外线消毒;
(3)、把消毒过的药粉存放在无菌车间,制成每粒含0.5g左右药粉的零号胶囊,再将胶囊装入瓶中,密闭容器保存备用即为成品。
本发明药物配伍中:
当归:甘、辛,温。归肝、心、脾经,功效:补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。主要化学成分:当归含有大量的挥发油、维生素、有机酸等多种有机成分微量元素。能扩张外周血管,降低血管阻力,增加循环血流量等。抑制黑色素的形成,对治疗黄褐斑、雀斑等色素性皮肤病收效良好,具有抗衰老和美容作用。另有抗缺氧、调节机体免疫功能、抗癌、抑菌、抗动脉硬化等作用。
西洋参:甘、微苦、凉。归心、肺、肾经。功能,补气养阴,清热生津。主治气虚阴亏,内热,咳喘痰血,虚热烦倦,消渴,口燥咽干。化学成分,主含人参皂甙。作为补气的保健首选药,西洋参有抗疲劳、抗氧化、抗应激、抑制血小板聚集、降低血液凝固性的作用,其独特之处在于不热不燥,对糖尿病患者还有调节血糖的作用。可以促进血清蛋白合成、骨髓蛋白合成、器官蛋白合成等,提高机体免疫力,抑制癌细胞生长,有效抵抗癌症。
白芍:苦酸,凉,入肝、脾经。功效:养血柔肝,缓急止痛,敛阴收汗。主治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热,月经不调,崩漏,带下。现代药理研究:白芍含有芍药甙、牡丹酚、芍药花甙等。可增加心肌血流量.芍药甙有较好的解痉作用,对肝脏有保护作用,又可增强巨噬细胞的吞噬功能。总之其可“扶阳气大除腹痛,收阴气陡健脾经。坠其胎能逐其血,损其肝能缓其中”。
桂枝:辛,甘温,归心、肺、膀胱经。功效,发汗解表,温经通阳。主要成分为挥发油。主治外感风寒,头痛发热恶寒,风寒湿痹,肩背肢解疼痛,心脾阳虚,阳气不行水湿内停而至的痰饮证,以及胸痹,胸痛或心悸,脉结代等症。还可用于经寒瘀滞,经闭,痛经癥瘕。
枸杞:甘平,归肝、肾、肺经,功能滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,阳痿遗精,内热消渴,血虚萎黄,目昏不明。现代医学研究证实其含有甜菜硷、多糖、粗脂肪、粗蛋白、胡萝卜素、维生素A、维生素C、维生素B2及钙、磷、铁、锌、锰、亚油酸等营养成分,对造血功能有促进作用,还有抗衰老、抗突变、抗肿瘤、抗脂肪肝及降血糖等作用。
山药:味甘,性平。归脾、肺、肾经。功效,益气养阴,补脾肺肾。主治:脾胃虚弱,饮食减少,便溏腹泻,脾虚带下,肺虚久咳咽干,肾虚遗精,尿频,消渴多饮。主要化学成分有淀粉酶、多酚氧化酶等,是一味平补脾胃的药食两用之品。现代药理研究,其含皂甙、黏液质,故可益肺气,养肺阴,治疗肺虚痰嗽久咳之症。又降低血糖,是糖尿病人的食疗佳品。其内大量的黏液蛋白、维生素及微量元素,有效阻止血脂在血管壁的沉淀,预防心血管疾病,益志安神、延年益寿。
黄芪:甘,温。 归肺、脾经。功效:补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴,慢性肾炎蛋白尿,糖尿病。化学成分 含黄酮类成分毛蕊异黄酮、3- 羟基- 9,10- 二甲氧基紫檀烷。蜜制黄芪益气补中。 用于气虚乏力,食少便溏。具体说来主要作用有四,即温肌肉而实腠理;益元气而补三焦;内托阴证之疮疡;固表虚之自汗。
菟丝子:味辛、甘,性微温;归肝、肾、脾经;功效:补肾益精、养肝明目、健脾固胎。主治:腰膝酸痛、阳痿、早泄、遗精、遗尿、尿频余沥、耳鸣、头眩眼花、视力减退、先兆流产、带下等症。主要化学成分,含生物碱、蒽醌、香豆素、黄酮、甙类、甾醇、鞣酸、糖类等。气和性缓,能浮能沉 。调补三阴,强胃气。
龙骨:甘涩,平。入心、肝、肾、大肠经。镇惊重镇安神,敛汗固精,止血涩肠,生肌敛疮。治惊痫癫狂,怔忡健忘,失眠多梦,自汗盗汗,遗精淋浊,吐衄便血,崩漏带下,泻痢脱肛,溃疡久不收口。主要成份含碳酸钙、磷酸钙。现代药理研究,其可促进血凝,降低血管壁通透性及抑制骨骼肌兴奋。
杜仲:甘,微辛,温。入肝、肾经,功效:补肝肾,强筋骨,安胎。主治:腰脊酸疼,足膝痿弱,小便余沥,阴下湿痒,胎漏欲堕,胎动不安。主要化学成分,含木脂素及其甙类物质。现代药理研究,其能增强肾上腺皮质功能,增强机体免疫力,降压,对子宫收缩药有拮抗作用,减少胆固醇的吸收,有“植物黄金”之称。
牡蛎:咸,微寒,归肝、胆、肾经。功效,平肝潜阳,重镇安神,软坚散结,收敛固涩。主治眩晕耳鸣,惊悸失眠,瘰疬瘿瘤,症瘕痞块,自汗盗汗,遗精,崩漏,带下,主要成分含碳酸钙、磷酸钙及硫酸钙,并含镁、铝、硅及氧化铁等.为制酸剂,有和胃镇痛作用,
肉苁蓉:味甘、咸,性温。功效补肾阳,益精血,润肠通便,主治阳痿,不孕,腰膝酸软,筋骨无力,肠燥便秘。主含微量生物碱、多糖和无机盐。具有降低血压、抗动脉粥样硬化的作用,抗衰老,能提高小肠推进度,能明显抑制大肠对水分的吸收。缩短通便时间。
淫羊藿:辛、甘,温。归肝、肾经。功能:补肾阳,强筋骨,祛风湿。主治:肾虚阳痿、遗精早泄、腰膝痿软、肢冷畏寒,寒湿痹痛或四肢拘挛麻木,不孕,步履艰难,喘咳短气。主要含黄酮类化合物、木脂素、生物碱、挥发油等主要化学成分。体轻气雄,可升可降。现代药理研究:可防治骨质疏松,提高白细胞生成、促进蛋白质合成、抗心肌缺氧、降压,并有激素样作用。
泽泻:甘、淡、寒,归肾,膀胱经。功效利水,渗湿,泄热。主治小便不利,水肿胀满,呕吐,泻痢,痰饮,脚气,淋病,尿血。化学成分:泽泻醇。亦有明显的降胆固醇作用、可抑制结核杆菌的生长。
丹皮:苦,辛,微寒,归心、肝、肾经。功效:清热凉血,活血散瘀。主治热病热入血分,发斑,吐衄热泪盈眶,热伏阴分发热,阴虚骨蒸潮热,血滞经闭,痛经,痈肿疮毒,跌扑伤痛,风湿热痹。化学成分:丹皮酚。现代药理研究:丹皮可增加冠脉血流量,减少心输出量,有保护心脏、抗炎、抑菌、抗凝等作用。
熟地:甘,微温。归肝、肾经。功效:补血养阴,填精益髓。主治虚诸证及阴虚血少,脑髓空虚所至的腰膝痿弱、劳嗽骨蒸,遗精,崩漏,月经不调,消渴,溲数,耳聋、目昏,心悸失眠、健忘,盗汗等。现代药理研究:有显著的降压作用,调节异常的甲状腺激素状态。为补肾阴之要药。古人谓之“大补五脏真阴”,“大补真水”。
桂枝:辛,甘温,归心、肺、膀胱经。功效发汗解表,温经通阳。主要成分为挥发油。主治外感风寒,头痛发热恶寒,风寒湿痹,肩背肢节疼痛,心脾阳虚,阳气不行,水湿内停而至的痰饮证,以及胸痹,胸痛或心悸,脉结代等症。还可用于经寒瘀滞,经闭,痛经癥瘕。
茯苓: 味甘淡,平,入心、肺、脾经。具有渗湿利水,健脾和胃,宁心安神的功效。可治小便不利,水肿胀满,痰饮咳逆,呕逆,恶阻,泄泻,遗精,淋浊,惊悸,健忘等症。其他作用:健脾利尿,抗菌,抗肿瘤。
陈皮:性温,味辛、味苦。入脾、胃、肺经。 功效,理气健脾,调中,燥湿,化痰。主治 脾胃气滞之脘腹胀满或疼痛、消化不良,湿浊阻中之胸闷腹胀、纳呆便溏,痰湿壅肺之咳嗽气喘。主含有挥发油,温能行气,辛能发散,苦而泄水。故陈皮可:导胸中寒邪,破滞气,益脾胃。
柴胡:苦,微寒, 归肝、胆经。功能:疏散退热,升阳舒肝。主治:感冒发热、寒热往来、疟疾,肝郁气滞,胸肋胀痛,脱肛,子宫脱落,月经不调。其成分主要含柴胡皂苷,甾醇,挥发油,脂肪酸和多糖等。
大枣:甘,温。归脾、胃经。功效,补中益气,养血安神。主用于脾虚食少,乏力便溏,妇人脏躁。大枣作为中药应用已有2000多年的历史,主要用于中气不足、脾胃虚弱、体倦乏力、食少便溏、血虚萎黄、妇女脏躁等证的治疗。药理研究发现,大枣中含有多种生物活性物质,如大枣多糖、黄酮类、皂苷类、三萜类、生物碱类、环磷酸腺苷、环磷酸乌苷等,对人体有多种保健治病功效,从临床应用上看服用大枣对于轻度失眠不失为较好的辅助治疗。
慢性疲劳综合征是免疫功能不足,削弱了机体的抗病能力,破坏了防御疾病的天然屏障所出现的一系列不足的症候群。所以在治疗上主要是提高机体免疫力,调养肾、肝、脾,使肾之阴阳平衡,脾气健旺,肝之藏血及疏泄功能调达,心气豁达,并且各脏腑功能协调,以上证侯自愈。
本发明的有益效果为:
1、本发明用药合理,配伍科学。本发明配伍中,方析如下:因本病病因病机,临床涉及五脏六腑,主要以肝、脾、肾为主,故而在治疗方面谨守病机,以补肾健脾为主,又乙癸同源,故而肝肾同治。本方组成是由六味地黄汤、桂枝汤、桂枝加龙骨牡蛎汤、四物汤加减而就。方中六味地黄汤(熟地、山茱萸、山药、泽泻、茯苓、牡丹皮)合仙茅、淫羊藿、杜仲、肉苁蓉、菟丝子滋补肾阴肾阳,主治肝肾虚弱所致的各种病症,如腰膝酸软、头晕耳鸣,盗汗,畏寒肢冷,男子遗精,阳痿早泄,女子月经失调,不孕等。取其“善补阴者必阳中求阴,阴得阳胜则源泉不竭;善补阳者必阴中取阳,阳得阴助则生化无穷”。共为君药。 方中重用黄芪并合西洋参大补后天脾胃之气,加桂枝汤(出自伤寒论),主治病症如肢体疲乏,肌肉关节疼痛,腹痛腹泻,面肌松弛等脾虚不足之症,又桂枝加龙骨牡蛎汤出自《伤寒杂病论》“夫失精家,少腹弦急,阴头寒,目眩发落,,脉极虚芤迟,为清谷,亡血,失精。脉得诸芤动微紧,男子失精,女子梦交,桂枝加龙骨牡蛎汤主之。”当归、白芍、熟地即四物汤去川芎,养肝血活血调经,治诸虚不足。合而为臣。方中柴胡疏肝解郁,升举阳气,主治月经失调,胁肋疼痛,头晕头痛,并为肝经之引经药;取陈皮一味补益每兼理气,补而不滞,调理脾胃之意;大枣补中益气,调和诸药。共为佐使之用。综观全方,药物配伍合理,用药结构严谨,以经方使用为主,肝脾肾同调,辩证确切,效如桴鼓;
2、本发明经临床治疗300余例患者,有效率达92%,治愈率达88%;
3、本发明工艺简单,治疗方便,见效快,无毒副作用,愈后不复发,费用成本低。
本发明用法为口服,用量:每次3粒(共含生药1.5g左右),一日三次。
具体实施方式
具体实施中,治疗慢性疲劳综合症的中药可以按以下列列表进行配方:
组别 | 熟地 | 茯苓 | 泽泻 | 枸杞 | 丹皮 | 山药 | 黄芪 | 桂枝 | 白芍 | 柴胡 | 陈皮 | 仙茅 | 淫羊藿 | 龙骨 | 牡蛎 | 当归 | 肉苁蓉 | 西洋参 | 大枣 | 杜仲 | 菟丝子 |
1 | 30 | 20 | 15 | 10 | 12 | 30 | 15 | 12 | 10 | 12 | 15 | 20 | 30 | 20 | 20 | 12 | 30 | 15 | 10 | 20 | 15 |
2 | 12 | 15 | 10 | 10 | 10 | 30 | 30 | 10 | 12 | 10 | 10 | 15 | 15 | 30 | 30 | 10 | 20 | 10 | 10 | 12 | 20 |
3 | 30 | 10 | 12 | 20 | 12 | 20 | 15 | 10 | 20 | 12 | 9 | 10 | 10 | 15 | 15 | 15 | 10 | 9 | 9 | 10 | 10 |
4 | 15 | 12 | 10 | 12 | 10 | 15 | 10 | 15 | 12 | 30 | 30 | 12 | 12 | 15 | 15 | 10 | 10 | 12 | 10 | 10 | 12 |
5 | 12 | 15 | 10 | 15 | 12 | 15 | 15 | 12 | 10 | 6 | 8 | 9 | 9 | 20 | 20 | 12 | 15 | 10 | 10 | 8 | 15 |
在此五组中:第一组药量相对较大,尤其补阳药药量较大,恐阳热过重;第三组,补阴药剂量相对过大,常服易致滋腻;第四组中补气药量较小,而升发、
理气药药物量较大,久服易伤阳气;第五组中,药物剂量大小不一,参差不齐,有的达不到治疗量,配伍不合理;第二组从药物的剂量来看,温阳药和滋阴药,配伍合理,阴阳双补,寒热适宜,临床疗效较好,故我们选择第二组。
实施例1:按表中的第2组取值进行药物配伍:
当归10,桂枝10,白芍12,熟地12, 枸杞10,黄芪 30, 菟丝子20,山药30,淫羊藿15,肉苁蓉 20, 杜仲12,茯苓15,西洋参10,陈皮10,牡蛎30,柴胡10,仙茅15,泽泻10,丹皮10,龙骨30,大枣10
药物的制备过程为:
(1)、按重量份取各原料混匀,再用粉碎机粉碎,后过80目筛,得药粉;
(2)、药粉用紫外线消毒;
(3)、把消毒过的药粉存放在无菌车间,制成每粒含0.5g药粉的零号胶囊,再将胶囊装入瓶中,密闭容器保存备用即为成品。
用法为口服,用量:每次3粒(共含生药1.5g),一日三次。
典型病例:
1 、赵某,男,40岁,行政机关公务员,初诊时间2009年9月18日。门诊号27546。主诉:头疼头晕,失眠多梦伴疲倦乏力半年余,加重十天。患者系行政干部,日理万机,近半年来开始感失眠多梦,精神焦虑,头痛头晕耳鸣,记忆力减退,食欲欠佳,伴腰膝酸软,性欲减退,畏寒肢冷,现加重十余天。心电图、脑电图、B超、各项化验检查均未发现异常。曾服安眠及调节神经的西药,症状稍缓,没达到根治。观其面色萎黄,精神萎顿,满脸倦态,体态虚胖,舌淡苔薄脉沉细。拟诊:慢性疲劳综合征,脾肾虚弱,治疗原则:滋补肝肾,益气健脾。给予实施例1,口服,每日三次,一次三粒,连服30天。10月23日复诊,精神较好,诉以上症状均有改善,效不更方,继服30天,病症痊愈,并且精神爽朗,面色红润光泽。嘱其调情志,适寒温,作息有时,加强锻炼。
2、刘某,女,35岁。经商。初诊时间2009年2月8日,门诊号25817。主诉:人流后月经失调半年余。患者2008年8月流产后,由于生意较忙,未得到很好的休息,经常饮食起居无规律,逐渐月经失调,一月两次或2月一至,伴腰酸乏力,失眠多梦,头晕耳鸣,易于烦躁,面部起黄褐斑,性欲淡漠,因此夫妻感情不好。B超检查子宫附件未见明显异常,妇科检查无异常。末次月经2月2日。根据其病史及体征,观其舌淡,苔薄白,按脉沉细弦。诊断:1、慢性疲劳综合症 2、月经失调。治疗原则:滋补肝肾阴阳,疏肝健脾调经。给予实施例1,每次三粒,一日三次,白开水冲服。连服一个月。2009年3月15日再诊,本次月经3月1日来潮,经量、经质正常,面部色斑变淡,其他症状均有减轻,效不更方,上药继服一个月,以上症状消失,半年后随访一切正常。
3、张某,男,44岁。教师。初诊时间2010年3月19日,门诊号23894。主诉:腰膝酸软,四肢乏力,失眠多梦2月余。患者系中学教师,现任班主任,平时较忙碌,不能按时作息,近期常感疲乏无力,腰膝酸软,失眠多梦,食欲欠佳,夜间出汗,畏寒肢冷伴烦躁易怒,情绪异常。观其面色萎黄,神倦乏力,少气懒言,舌淡齿痕,脉虚细。拟诊:慢性疲劳综合症,脾肾虚弱证。治疗原则:益肾健脾,疏肝理气。给予实施例1,口服,每次三粒,一日三次,白开水冲服。连服一个月。4月30日复诊,睡眠较好,无腰膝酸软,其他症状均有不同程度的改善,效不更方,继予上方连服两个月,嘱其适当调节作息时间,适寒温,调情志,少吃辛辣。半年后随访伴随症状消失,神清气爽。
Claims (3)
1.一种治疗慢性疲劳综合症的中药,其特征在于,其是由下列重量份的原料药制成:当归10-15,桂枝10-12,白芍10-15,熟地10-15, 枸杞10-12,黄芪 15-30, 菟丝子10-20,山药30-60,淫羊藿10-15,肉苁蓉 15-30,杜仲10-15,茯苓10-20,西洋参10-12,陈皮10-12,牡蛎15-30,柴胡10-12,仙茅10-15,泽泻10-12,丹皮10-15,龙骨15-30,大枣10-15。
2.根据权利要求1所述的治疗慢性疲劳综合症的中药,其特征在于:其是由下列重量份的原料药制成:当归10,桂枝10,白芍12,熟地12, 枸杞10,黄芪 30, 菟丝子20,山药30,淫羊藿15,肉苁蓉 20, 杜仲12,茯苓15,西洋参10,陈皮10,牡蛎30,柴胡10,仙茅15,泽泻10,丹皮10,龙骨30,大枣10。
3.根据权利要求1所述的治疗慢性疲劳综合症的中药,其特征在于:制备方法包括以下步骤:
(1)、按重量份取各原料混匀,再用粉碎机粉碎,后过80目筛,得药粉;
(2)、药粉用紫外线消毒;
(3)、把消毒过的药粉存放在无菌车间,制成每粒含0.5g左右药粉的零号胶囊,再将胶囊装入瓶中,密闭容器保存备用即为成品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210192314.7A CN102727711B (zh) | 2012-06-12 | 2012-06-12 | 一种治疗慢性疲劳综合症的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210192314.7A CN102727711B (zh) | 2012-06-12 | 2012-06-12 | 一种治疗慢性疲劳综合症的中药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102727711A true CN102727711A (zh) | 2012-10-17 |
CN102727711B CN102727711B (zh) | 2014-04-02 |
Family
ID=46984475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210192314.7A Expired - Fee Related CN102727711B (zh) | 2012-06-12 | 2012-06-12 | 一种治疗慢性疲劳综合症的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102727711B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446495A (zh) * | 2013-08-14 | 2013-12-18 | 马靖已 | 一种治疗慢性疲劳综合症的中药 |
CN105125958A (zh) * | 2015-09-06 | 2015-12-09 | 李蕴 | 一种润肤养容的中药原粉及用途 |
CN105596716A (zh) * | 2016-03-12 | 2016-05-25 | 车莉 | 一种治疗脾虚痰湿型慢性疲劳综合症的中药组合物 |
CN106343544A (zh) * | 2016-06-08 | 2017-01-25 | 安徽华瑞医药技术开发有限公司 | 一种缓解慢性疲劳综合征的功能性食品 |
CN116392569A (zh) * | 2023-04-17 | 2023-07-07 | 天津市武清区爱康中医医院 | 一种用于增强记忆力的中药制剂及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030031732A1 (en) * | 2001-05-15 | 2003-02-13 | Kim Won Kyu | Anti-fatigue and tonic agent containing wild ginseng |
CN1413630A (zh) * | 2002-05-31 | 2003-04-30 | 徐国勇 | 治疗过作爱、熬夜、疲劳、记忆差、机体免疫低下、内分泌紊乱的药物 |
US20050106276A1 (en) * | 2001-11-29 | 2005-05-19 | Jiangsu Kanion Pharmaceutial Co. Ltd. | Pharmaceutical composition made from Chinese traditional medecine and method of producing thereof |
CN1772161A (zh) * | 2005-05-26 | 2006-05-17 | 李琦白 | 一种治疗精液异常的中药方剂 |
CN101744965A (zh) * | 2008-12-06 | 2010-06-23 | 万广灿 | 治疗亚健康的中草药组合物及其制作方法 |
CN101940694A (zh) * | 2010-08-28 | 2011-01-12 | 穆志明 | 一种调理人体亚健康的药物 |
CN102302624A (zh) * | 2011-09-16 | 2012-01-04 | 沈庆利 | 一种补益肝肾的中药组合物 |
-
2012
- 2012-06-12 CN CN201210192314.7A patent/CN102727711B/zh not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030031732A1 (en) * | 2001-05-15 | 2003-02-13 | Kim Won Kyu | Anti-fatigue and tonic agent containing wild ginseng |
US20050106276A1 (en) * | 2001-11-29 | 2005-05-19 | Jiangsu Kanion Pharmaceutial Co. Ltd. | Pharmaceutical composition made from Chinese traditional medecine and method of producing thereof |
CN1413630A (zh) * | 2002-05-31 | 2003-04-30 | 徐国勇 | 治疗过作爱、熬夜、疲劳、记忆差、机体免疫低下、内分泌紊乱的药物 |
CN1772161A (zh) * | 2005-05-26 | 2006-05-17 | 李琦白 | 一种治疗精液异常的中药方剂 |
CN101744965A (zh) * | 2008-12-06 | 2010-06-23 | 万广灿 | 治疗亚健康的中草药组合物及其制作方法 |
CN101940694A (zh) * | 2010-08-28 | 2011-01-12 | 穆志明 | 一种调理人体亚健康的药物 |
CN102302624A (zh) * | 2011-09-16 | 2012-01-04 | 沈庆利 | 一种补益肝肾的中药组合物 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446495A (zh) * | 2013-08-14 | 2013-12-18 | 马靖已 | 一种治疗慢性疲劳综合症的中药 |
CN105125958A (zh) * | 2015-09-06 | 2015-12-09 | 李蕴 | 一种润肤养容的中药原粉及用途 |
CN105596716A (zh) * | 2016-03-12 | 2016-05-25 | 车莉 | 一种治疗脾虚痰湿型慢性疲劳综合症的中药组合物 |
CN106343544A (zh) * | 2016-06-08 | 2017-01-25 | 安徽华瑞医药技术开发有限公司 | 一种缓解慢性疲劳综合征的功能性食品 |
CN116392569A (zh) * | 2023-04-17 | 2023-07-07 | 天津市武清区爱康中医医院 | 一种用于增强记忆力的中药制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102727711B (zh) | 2014-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102274398B (zh) | 一种女士保健药酒及其制备方法 | |
CN104146261B (zh) | 一种妇女更年期的中药保健品及其制备方法 | |
CN102727711B (zh) | 一种治疗慢性疲劳综合症的中药 | |
CN104147552A (zh) | 一种治疗血瘀型产后腹痛的中药组合物及其制备方法 | |
CN104524335A (zh) | 一种用于女性内分泌失调调理的药丸及制备方法 | |
CN102366541A (zh) | 一种治疗消渴病的中药组合物 | |
CN104225417A (zh) | 一种辅助改善记忆力功能的中药组合物及其制备方法 | |
CN102727761A (zh) | 治疗脂溢性脱发、防治头发干枯发叉的药物及其制备方法 | |
CN101953989A (zh) | 一种电磁波视康仪及中药组合物 | |
CN104056119A (zh) | 一种保健酒及其制备方法 | |
CN104225532B (zh) | 治疗强直性脊柱炎的健脾温肾丸 | |
CN103053767A (zh) | 一种苁蓉保健营养茶制备方法 | |
CN103212037B (zh) | 一种治疗女性内分泌紊乱的中药及其制备方法 | |
CN102652808B (zh) | 一种调经养容胶囊 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN104258300A (zh) | 一种治疗中风后遗症之气虚血瘀型的中药制剂及其制备方法 | |
CN101953990B (zh) | 一种动力波视康仪及中药组合物 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN104524524B (zh) | 一种治疗骨质疏松的药物及制备方法 | |
CN102579818A (zh) | 一种藏药组合物及其制备方法与应用 | |
CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
CN105213905A (zh) | 一种防治绝经后骨质疏松症的中药组合物及其应用 | |
CN104799276B (zh) | 一种麻七利血溶栓粉及其制备方法 | |
CN103356871A (zh) | 一种补肾壮阳的蚕蛹蛾保健药酒及其制备方法 | |
CN103285327B (zh) | 治疗冠心病的中药组合物片剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140402 |
|
CF01 | Termination of patent right due to non-payment of annual fee |